Cargando…

Gambogic acid reverses oxaliplatin resistance in colorectal cancer by increasing intracellular platinum levels

Resistance to oxaliplatin (L-OHP) is a major obstacle to successful chemotherapy in colorectal cancer (CRC). In the present study, the ability of gambogic acid (GA) to reverse L-OHP resistance in CRC LoVo cells was investigated. L-OHP-resistant LoVo/L-OHP cells were established by exposing them to i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Qiang, Wei, Jianchang, Wang, Chengxing, Zhang, Tong, Huang, Di, Wei, Fang, He, Feng, Cai, Wensong, Yang, Ping, Zeng, Shanqi, Li, Wanglin, Cao, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6036459/ https://www.ncbi.nlm.nih.gov/pubmed/30008940 http://dx.doi.org/10.3892/ol.2018.8916

Ejemplares similares

Gankyrin sustains PI3K/GSK-3β/β-catenin signal activation and promotes colorectal cancer aggressiveness and progression
por: He, Feng, et al.
Publicado: (2016)

Overexpression of transcription factor activating enhancer binding protein 4 (TFAP4) predicts poor prognosis for colorectal cancer patients
por: Wei, Jianchang, et al.
Publicado: (2017)

Establishment of multiple diagnosis models for colorectal cancer with artificial neural networks
por: Wang, Qiang, et al.
Publicado: (2019)

Genome-scale CRISPR-Cas9 knockout screening in gastrointestinal stromal tumor with Imatinib resistance
por: Cao, Jie, et al.
Publicado: (2018)

Expression of EZH2 is associated with poor outcome in colorectal cancer
por: Chen, Zhuanpeng, et al.
Publicado: (2018)

Hyaluronic acid-decorated redox-sensitive chitosan micelles for tumor-specific intracellular delivery of gambogic acid
por: Xu, Wei, et al.
Publicado: (2019)

A Gamboge Case
por: Biegler, J. A.
Publicado: (1887)

Platinum accumulation in oxaliplatin‐induced peripheral neuropathy
por: Wei, Guoli, et al.
Publicado: (2021)

Gambogic acid-loaded biomimetic nanoparticles in colorectal cancer treatment
por: Zhang, Zhen, et al.
Publicado: (2017)

Long noncoding RNA PVT1-214 promotes proliferation and invasion of colorectal cancer by stabilizing Lin28 and interacting with miR-128
por: He, Feng, et al.
Publicado: (2018)

Knockdown of PKM2 and GLS1 expression can significantly reverse oxaliplatin-resistance in colorectal cancer cells
por: Lu, Wei-Qun, et al.
Publicado: (2017)

Prognostic and biological function value of OSBPL3 in colorectal cancer analyzed by multi-omic data analysis
por: Wang, Chengxing, et al.
Publicado: (2023)

Investigations into the antibacterial effects and potential mechanism of gambogic acid and neogambogic acid
por: Li, Mingzhu, et al.
Publicado: (2022)

Tanshinone IIA Reverses Oxaliplatin Resistance In Human Colorectal Cancer Via Inhibition Of ERK/Akt Signaling Pathway
por: Zhang, Yonggang, et al.
Publicado: (2019)

Synthesis and Antiangiogenic Activity of Novel Gambogic Acid Derivatives
por: Chen, Tao, et al.
Publicado: (2012)

Gambogic acid inhibits growth, induces apoptosis, and overcomes drug resistance in human colorectal cancer cells
por: WEN, CHUANGYU, et al.
Publicado: (2015)

Improving aqueous solubility and antitumor effects by nanosized gambogic acid-mPEG(2000) micelles
por: Cai, Lulu, et al.
Publicado: (2013)

Long-term platinum retention after treatment with cisplatin and oxaliplatin
por: Brouwers, Elke EM, et al.
Publicado: (2008)

Gambogic Acid Induces Pyroptosis of Colorectal Cancer Cells through the GSDME-Dependent Pathway and Elicits an Antitumor Immune Response
por: Xu, Hanjie, et al.
Publicado: (2022)

Research Progress in the Field of Gambogic Acid and Its Derivatives as Antineoplastic Drugs
por: Li, Meng, et al.
Publicado: (2022)

Gambogic Acid Inhibits Gastric Cancer Cell Proliferation through Necroptosis
por: Wang, Shujun, et al.
Publicado: (2023)

Synergistic anti-proliferative effects of gambogic acid with docetaxel in gastrointestinal cancer cell lines
por: Zou, Zhengyun, et al.
Publicado: (2012)

Characterization in Dual Activation by Oxaliplatin, a Platinum-Based Chemotherapeutic Agent of Hyperpolarization-Activated Cation and Electroporation-Induced Currents
por: Chang, Wei-Ting, et al.
Publicado: (2020)

Oxaliplatin-Based Platinum(IV) Prodrug Bearing Toll-like Receptor 7 Agonist for Enhanced Immunochemotherapy
por: Tang, Li, et al.
Publicado: (2019)

Bromodomain-containing protein 4 is critical for the antiproliferative and pro-apoptotic effects of gambogic acid in anaplastic thyroid cancer
por: Wang, Yonghui, et al.
Publicado: (2018)

Targeting REV7 effectively reverses 5-FU and oxaliplatin resistance in colorectal cancer
por: Sun, Xianjun, et al.
Publicado: (2020)

Combined therapy with EGFR TKI and gambogic acid for overcoming resistance in EGFR-T790M mutant lung cancer
por: WANG, CHENGDE, et al.
Publicado: (2015)

Gambogic acid suppresses colon cancer cell activity in vitro
por: Zhou, Zailong, et al.
Publicado: (2019)

Gambogic Acid as a Candidate for Cancer Therapy: A Review
por: Liu, Yuling, et al.
Publicado: (2020)

Effect of Gambogic Acid on miR-199a-3p Expression and Cell Biological Behavior in Colorectal Cancer Cells
por: Wang, Xiaodong, et al.
Publicado: (2021)

Scutellarin resensitizes oxaliplatin-resistant colorectal cancer cells to oxaliplatin treatment through inhibition of PKM2
por: Sun, Wei, et al.
Publicado: (2021)

The Effect of Compound Sophora on Fluorouracil and Oxaliplatin Resistance in Colorectal Cancer Cells
por: Yin, WeiHua, et al.
Publicado: (2019)

Stereoselective peripheral sensory neurotoxicity of diaminocyclohexane platinum enantiomers related to ormaplatin and oxaliplatin.
por: Screnci, D., et al.
Publicado: (1997)

A platinum(IV) prodrug strategy to overcome glutathione-based oxaliplatin resistance
por: Fronik, Philipp, et al.
Publicado: (2022)

ROS-Mediated Autophagy Induced by Dysregulation of Lipid Metabolism Plays a Protective Role in Colorectal Cancer Cells Treated with Gambogic Acid
por: Zhang, Haiyuan, et al.
Publicado: (2014)

Aminated β-cyclodextrin-grafted Fe(3)O(4)-loaded gambogic acid magnetic nanoparticles: preparation, characterization, and biological evaluation
por: Fang, Wei, et al.
Publicado: (2019)

MiR-29b reverses oxaliplatin-resistance in colorectal cancer by targeting SIRT1
por: Liu, Hui, et al.
Publicado: (2018)

Gambogic Acid and Its Analogs Inhibit Gap Junctional Intercellular Communication
por: Choi, Eun J., et al.
Publicado: (2018)

Structural Optimization and Improving Antitumor Potential of Moreollic Acid from Gamboge
por: Cheng, Li-Zhi, et al.
Publicado: (2022)

Gambogic acid and juglone inhibit RNase P through distinct mechanisms
por: Wu Meyers, Nancy, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cdpujrb2c63e5b9c8igspm9q8t